Company Search:
Advanced Search
Sponsored Links
Edesa Biotech Inc Company Snapshot
Edesa Biotech Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Edesa Biotech Inc with three other companies in this sector in CANADA : Imv Inc (2020 sales of 301,000.00 Canadian Dollars [US$242,937.10 ] ), RepliCel Life Sciences Inc (353,735.00 Canadian Dollars [US$285,499.52 ] ), and Avisa Diagnostics Inc (372,072.71 Canadian Dollars [US$300,299.89 ] ).

Sales Analysis. During the year ended September of 2020, sales at Edesa Biotech Inc were C$441,461.37 (US$356.30 thousand). This is a sharp decrease of 39.3% versus 2019, when the company's sales were C$727,864.42 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Edesa Biotech Inc
  Stock Performance Chart for Edesa Biotech Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/22/2021): 9.49
(Figures in Canadian Dollars)
1 Week -1.7%   13 Weeks -7.9%  
4 Weeks 45.9%   52 Weeks 14.1%  
Edesa Biotech Inc Key Data:
  Ticker: EDSA Country: Canada
  Exchanges: NAS VEN Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 441,461
(Year Ending Jan 2021).
Employees: 6
  Currency: Canadian Dollars Market Cap: 125,849,603
  Fiscal Yr Ends: September Shares Outstanding: 13,255,559
  Share Type: Common Closely Held Shares: 3,821,047
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.